Treatment preferences of adult patients with hereditary fructose intolerance: A discrete choice experiment
Under specific conditions, patients with HFI prefer a pharmacological therapy over their fructose-restricted diet. Therapy-related factors as well as patient-related factors play a role in this choice. These findings may guide the development and implementation of a pharmacologic therapy for patients with HFI.
Authors
- Corrie Timmer (ORCID: https://orcid.org/0000-0002-9440-9645)
- M. Hiligsmann
- Javier de las Heras (ORCID: https://orcid.org/0000-0001-5663-537X)
- David Cassiman (ORCID: https://orcid.org/0000-0002-6154-0970)
- Lise E F Janssen
- Martijn C.G.J. Brouwers (ORCID: https://orcid.org/0000-0002-8229-3331)
- Liesbeth M.C. van der Ploeg (ORCID: https://orcid.org/0000-0002-5934-2983)
- Timothy M. Cox (ORCID: https://orcid.org/0000-0002-4951-9941)
- K. Vande Kerckhove (ORCID: https://orcid.org/0000-0001-7750-2939)
Institutions
- University of Cambridge (GB)
- Maastricht University Medical Centre (NL)
- Maastricht University (NL)
- BioCruces Health research Institute (ES)
- Amsterdam Neuroscience (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
- KU Leuven (BE)
Publication Details
- Journal
- Molecular Genetics and Metabolism
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1016/j.ymgme.2025.109169
- Citations
- 2
- Primary Topic
- Diet, Metabolism, and Disease
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- Stichting Stofwisselkracht